Patents by Inventor Piritta Koistinen

Piritta Koistinen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230119355
    Abstract: The present invention relates to pharmaceutical compositions comprising hydrochloride salt of N-(2?,4?-difluoro-5-(5-(1-methyl-1H-pyrazol-4-yl)-1H-benzo[d]imidazol-1-yl)-[1,1?-biphenyl]-3-yl)cyclopropanesulfonamide (I) as an active ingredient and copovidone as an excipient. Compound (I) is a selective inhibitor of FGFR/VEGFR kinase families and is useful in the treatment of cancer.
    Type: Application
    Filed: March 5, 2021
    Publication date: April 20, 2023
    Applicant: AURIGENE DISCOVERY TECHNOLOGIES LIMITED
    Inventors: Frederic DARGELAS, Piritta KOISTINEN, Laura LEIMU, Laura MATILAINEN, Henri METSALA, Anna SHEVCHENKO
  • Patent number: 8309591
    Abstract: The present invention relates to a veterinary composition in a semisolid form adapted for transmucosal administration for providing sedation and analgesia in large animals such as horses and cattle. The semisolid transmucosal composition of the invention comprises detomidine or a pharmaceutically acceptable salt thereof as an active ingredient. The composition provides a rapid onset of action while having low irritation potential in the oral mucosa.
    Type: Grant
    Filed: November 24, 2010
    Date of Patent: November 13, 2012
    Assignee: Orion Corporation
    Inventors: Mirja Huhtinen, Piritta Koistinen, Lasse Leino, Maria Rantala, Helena Kaukinen, Kaija Af Ursin
  • Publication number: 20110071203
    Abstract: The present invention relates to a veterinary composition in a semisolid form adapted for transmucosal administration for providing sedation and analgesia in large animals such as horses and cattle. The semisolid transmucosal composition of the invention comprises detomidine or a pharmaceutically acceptable salt thereof as an active ingredient. The composition provides a rapid onset of action while having low irritation potential in the oral mucosa.
    Type: Application
    Filed: November 24, 2010
    Publication date: March 24, 2011
    Applicant: Orion Corporation
    Inventors: Mirja Huhtinen, Piritta Koistinen, Lasse Leino, Maria Rantala, Helena Kaukinen, Kaija AF Ursin
  • Patent number: 7863311
    Abstract: The present invention relates to a veterinary composition in a semisolid form adapted for transmucosal administration for providing sedation and analgesia in large animals such as horses and cattle. The semisolid transmucosal composition of the invention comprises detomidine or a pharmaceutically acceptable salt thereof as an active ingredient. The composition provides a rapid onset of action while having low irritation potential in the oral mucosa.
    Type: Grant
    Filed: November 3, 2005
    Date of Patent: January 4, 2011
    Assignee: Orion Corporation
    Inventors: Mirja Huhtinen, Piritta Koistinen, Lasse Leino, Maria Rantala, Helena Kaukinen, Kaija Af Ursin
  • Publication number: 20070299121
    Abstract: The present invention relates to a veterinary composition in a semisolid form adapted for transmucosal administration for providing sedation and analgesia in large animals such as horses and cattle. The semisolid transmucosal composition of the invention comprises detomidine or a pharmaceutically acceptable salt thereof as an active ingredient. The composition provides a rapid onset of action while having low irritation potential in the oral mucosa.
    Type: Application
    Filed: November 3, 2005
    Publication date: December 27, 2007
    Inventors: Mirja Huhtinen, Piritta Koistinen, Lasse Leino, Maria Rantala, Helena Kaukinen, Kaija Af Ursin